About the Authors
- Sara J. Whitehead
-
* E-mail: svw7@th.cdc.gov
Affiliation Thailand Ministry of Public Health–U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
- Catherine McLean
-
Affiliation National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
- Supaporn Chaikummao
-
Affiliation Thailand Ministry of Public Health–U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
- Sarah Braunstein
-
Affiliation Population Council, New York, New York, United States of America
- Wat Utaivoravit
-
Affiliation Chiang Rai Hospital, Chiang Rai, Thailand
- Janneke H. van de Wijgert
-
Affiliations Population Council, New York, New York, United States of America, Academic Medical Center of the University of Amsterdam and Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands
- Philip A. Mock
-
Affiliation Thailand Ministry of Public Health–U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
- Taweesap Siraprapasiri
-
Affiliation Thailand Ministry of Public Health–U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
- Barbara A. Friedland
-
Affiliation Population Council, New York, New York, United States of America
- Peter H. Kilmarx
-
Affiliation National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
- Lauri E. Markowitz
-
Affiliation National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
Competing Interests
None of the authors have a commercial association with Carraguard or other conflicts of interest. Carraguard® is being developed by the Population Council, which is a not-for-profit nongovernmental organization, under a U.S. Food and Drug Administration Investigational New Drug Application (IND 58,441).
Author Contributions
Conceived and designed the experiments: JvdW CAM BF PHK LEM. Performed the experiments: CAM SC. Analyzed the data: SJW PAM. Wrote the manuscript: SJW. Contributed to study monitoring and implementation: JvdW. Supervised field staff: SJW SC. Developed Standard Operating Procedures, monitored trial conduct, contributed to analysis of acceptability data: SB. Coordinated field site support and referral: WU. Coordinated field staff supervision and implementation: TS. Supported implementation of the study: BF. Supervised implementation of the study: PHK LEM.